Axiommax Oncology Private Limited - Company Profile

It is a healthcare private limited company based in Mumbai, Maharashtra, India, established in 2016.
2016 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Axiommax Oncology Private Limited

Axiommax Oncology Private Limited, a active private limited company, was established on 03 August 2016 in Mumbai, Maharashtra, India. Engaging in oncology clinics & cancer treatment within the healthcare sector, it holds CIN: U24110MH2016PTC284390. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Employing 31 professional, Its leadership includes Uttamchand Kesharimal Jain (Director), Ashokkumar Keshrimal Jain (Director). Its latest AGM occurred on 22 September 2025, with the balance sheet filed on 31 March 2025. It is based at 146, Damji Shamji Industrial Complex, 28 Mahal Indust. Estate, Mahakali Caves Road, And, Heri East,, Mumbai, Maharashtra, 400093.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24110MH2016PTC284390

  • Registration Number

    284390

  • Incorporation Date

    03 August 2016

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 83.80%
  • Profit Growth **** 6.99%
  • Ebitda **** -238.48%
  • Net Worth -27.21%
  • Total Assets **** 67.45%
Company report

Axiommax Oncology Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Axiommax Oncology Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Axiommax Oncology Private Limited?
Current Directors
Name Designation Appointment Date Status
Uttamchand Kesharimal Jain Director 03 Aug 2016 Current
Ashokkumar Keshrimal Jain Director 03 Aug 2016 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Axiommax Oncology.

Axiommax Oncology Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 83.8% increase. The company also saw a slight improvement in profitability, with a 6.99% increase in profit. The company's net worth observed a substantial decline by a decrease of 27.21%.

Axiommax Oncology revenue growth over time
Axiommax Oncology profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 83.80%
*******
*******
*******
*******
Revenue from Operations
*******
 83.79%
*******
*******
*******
*******
Total Assets
*******
 67.45%
*******
*******
*******
*******
Profit or Loss
*******
 6.99%
*******
*******
*******
*******
Net Worth
*******
 -27.21%
*******
*******
*******
*******
EBITDA
*******
 -238.48%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Axiommax Oncology?

In 2019, Axiommax Oncology had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Axiommax Oncology?

Axiommax Oncology has a workforce of 31 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Axiommax Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axiommax Oncology's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Axiommax Oncology
Recent Activity within the Organization
  • Annual General Meeting

    Axiommax Oncology Private Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Axiommax Oncology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Uttamchand Kesharimal Jain was appointed as a Director was appointed as a Director on 03 Aug 2016 & has been associated with this company since 9 years 6 months . was completed.

  • Director Appointment

    Ashokkumar Keshrimal Jain was appointed as a Director was appointed as a Director on 03 Aug 2016 & has been associated with this company since 9 years 6 months . was recorded as a recent event.

  • Company Incorporation

    The activity Axiommax Oncology Private Limited was registered on 03 Aug 2016 with Roc Mumbai & aged 9 years 6 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Axiommax Oncology Private Limited?

The CIN of Axiommax Oncology Private Limited is U24110MH2016PTC284390.

Where is Axiommax Oncology Private Limited headquartered?

Axiommax Oncology Private Limited is headquartered at 146, Damji Shamji Industrial Complex, 28 Mahal Indust. Estate, Mahakali Caves Road, And, Heri East,, Mumbai, Maharashtra, 400093.

When was Axiommax Oncology Private Limited incorporated?

Axiommax Oncology Private Limited was incorporated on 03 August 2016.

Who are the current directors of Axiommax Oncology Private Limited?

The current directors of Axiommax Oncology Private Limited are

What is the primary industry of Axiommax Oncology Private Limited?

The primary industry of Axiommax Oncology Private Limited is Healthcare.

Is Axiommax Oncology Private Limited a listed company?

Axiommax Oncology Private Limited is unlisted.

What is the capital structure of Axiommax Oncology Private Limited?

The authorized capital of Axiommax Oncology Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Axiommax Oncology Private Limited?

The compliance status of Axiommax Oncology Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available